SCHEMBL7830864

SCHEMBL7830864

CS(=O)(=O)ONC(N)=NC(=O)c1cccc(-c2ccsc2C#N)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 7/20 0.34
PGR P06401 1/20 0.32
HTR1A P08908 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
CCKAR P32238 1/20 0.32
HTR5A P47898 1/20 0.32
BTK Q06187 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30
SCN9A Q15858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7830859 0.87 SLC9A1 (0.46) SLC9A1
SCHEMBL8441632 0.85 BCAT2 (0.37) SLC9A1HTR1AADORA3CCKARHTR5A
SCHEMBL8444041 0.85 CA12 (0.37) SLC9A1HTR1AADORA3CCKARHTR5A
SCHEMBL8441543 0.82 SLC9A1 (0.34) SLC9A1HTR1AADORA3CCKARHTR5A
SCHEMBL1387943 0.82 SLC9A1 (0.40) SLC9A1
SCHEMBL8440989 0.81 SLC9A1 (0.43) SLC9A1
SCHEMBL7816360 0.80 SLC9A1 (0.34) SLC9A1CA12CA1CA2CA9
Guanidine SCHEMBL8705964 0.78 CA12 (0.35) PGRBTKCA12CA1CA2
SCHEMBL8440927 0.77 HDAC2 (0.46) SLC9A1
SCHEMBL8440628 0.77 SLC9A1 (0.40) SLC9A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699185-B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO (JP) 2001-09-05 EP disclosed
EP-0699185-A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-03-06 EP disclosed